In focus
Latest feed
Myqorzo Shines: Cytokinetics' Aficamten Delivers Hope for Non-Obstructive HCM Patients
Stoke Therapeutics’ Dravet‑Syndrome Gene Therapy Nears the Finish Line
Viridian Therapeutics’ LUMVOA Gets FDA Nod, Poised for Market Debut
Pfizer Shares Slip After Seagen’s Origin Cancer Drug Delivers Mixed Top‑line Results
